NO20026255L - Polymere micellesammensetninger - Google Patents

Polymere micellesammensetninger

Info

Publication number
NO20026255L
NO20026255L NO20026255A NO20026255A NO20026255L NO 20026255 L NO20026255 L NO 20026255L NO 20026255 A NO20026255 A NO 20026255A NO 20026255 A NO20026255 A NO 20026255A NO 20026255 L NO20026255 L NO 20026255L
Authority
NO
Norway
Prior art keywords
polymeric micelle
micelle compositions
compositions
polymeric
therapeutic agents
Prior art date
Application number
NO20026255A
Other languages
English (en)
Other versions
NO20026255D0 (no
Inventor
Jean-Christophe Leroux
Amina Souad Nahmed
Original Assignee
Labopharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Labopharm Inc filed Critical Labopharm Inc
Publication of NO20026255D0 publication Critical patent/NO20026255D0/no
Publication of NO20026255L publication Critical patent/NO20026255L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00Nanotechnology
    • Y10S977/902Specified use of nanostructure
    • Y10S977/904Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/906Drug delivery
NO20026255A 2000-06-29 2002-12-27 Polymere micellesammensetninger NO20026255L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/606,398 US6338859B1 (en) 2000-06-29 2000-06-29 Polymeric micelle compositions
PCT/CA2001/000963 WO2002000194A2 (en) 2000-06-29 2001-06-28 Polymeric micelle compositions

Publications (2)

Publication Number Publication Date
NO20026255D0 NO20026255D0 (no) 2002-12-27
NO20026255L true NO20026255L (no) 2003-02-25

Family

ID=24427804

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20026255A NO20026255L (no) 2000-06-29 2002-12-27 Polymere micellesammensetninger

Country Status (23)

Country Link
US (1) US6338859B1 (no)
EP (1) EP1296647B1 (no)
JP (1) JP5134179B2 (no)
KR (1) KR20030039332A (no)
CN (1) CN1258358C (no)
AT (1) ATE336229T1 (no)
AU (2) AU7040501A (no)
BR (1) BR0112054A (no)
CA (1) CA2414241C (no)
CZ (1) CZ302369B6 (no)
DE (1) DE60122335T2 (no)
DK (1) DK1296647T3 (no)
ES (1) ES2271039T3 (no)
HK (1) HK1059395A1 (no)
HU (1) HUP0300963A2 (no)
IL (2) IL153655A0 (no)
MX (1) MXPA03000065A (no)
NO (1) NO20026255L (no)
NZ (1) NZ523645A (no)
PL (1) PL202475B1 (no)
PT (1) PT1296647E (no)
RU (1) RU2308943C2 (no)
WO (1) WO2002000194A2 (no)

Families Citing this family (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL119660A (en) 1993-05-10 2002-09-12 Euro Celtique Sa Controlled release formulation comprising tramadol
AU2001258117A1 (en) 2000-05-08 2001-11-20 The University Of British Columbia Supports for photosensitizer formulations
HUP0303719A2 (hu) * 2000-10-16 2004-03-01 Neopharm, Inc. Mitoxantron hatóanyag-tartalmú liposzómás gyógyszerkészítmények és eljárás az előállításukra
CA2428784A1 (en) * 2000-11-09 2002-05-16 Astrazeneca Ab Oral pharmaceutical composition containing a block copolymer
US6939564B2 (en) * 2001-06-08 2005-09-06 Labopharm, Inc. Water-soluble stabilized self-assembled polyelectrolytes
US6780428B2 (en) * 2001-06-08 2004-08-24 Labopharm, Inc. Unimolecular polymeric micelles with an ionizable inner core
JP2004535431A (ja) * 2001-06-22 2004-11-25 サザン バイオシステムズ, インコーポレイテッド ゼロ次長期放出同軸インプラント
KR100481540B1 (ko) * 2002-02-26 2005-04-07 한국전자통신연구원 치료 약물 함유된 스마트 나노 입자의 제조 방법
DE60335608D1 (de) * 2002-02-27 2011-02-17 Pharmain Corp Zusammensetzungen zur abgabe von therapeutika und anderen materialien und verfahren zu ihrer herstellung und verwendung
US7635463B2 (en) * 2002-02-27 2009-12-22 Pharmain Corporation Compositions for delivery of therapeutics and other materials
US20050260259A1 (en) * 2004-04-23 2005-11-24 Bolotin Elijah M Compositions for treatment with glucagon-like peptide, and methods of making and using the same
US6780324B2 (en) * 2002-03-18 2004-08-24 Labopharm, Inc. Preparation of sterile stabilized nanodispersions
US7018655B2 (en) * 2002-03-18 2006-03-28 Labopharm, Inc. Amphiphilic diblock, triblock and star-block copolymers and their pharmaceutical compositions
AU2003230761A1 (en) * 2002-03-29 2003-10-13 Abbott Laboratories Polymeric micelle formulations of hydrophobic compounds and methods
EP1393718A1 (en) * 2002-08-29 2004-03-03 OctoPlus Sciences B.V. Colloidal drug carrier system
ES2686361T3 (es) * 2002-10-29 2018-10-17 Insmed Incorporated Liposomas que comprenden un aminoglucósido para el tratamiento de infecciones pulmonares
US7879351B2 (en) * 2002-10-29 2011-02-01 Transave, Inc. High delivery rates for lipid based drug formulations, and methods of treatment thereof
US7718189B2 (en) 2002-10-29 2010-05-18 Transave, Inc. Sustained release of antiinfectives
KR100508518B1 (ko) * 2002-11-13 2005-08-17 한미약품 주식회사 초임계유체 공정을 이용한 파클리탁셀 고체분산체의 제조방법 및 이 방법으로 제조된 파클리탁셀 고체분산체
US7491395B2 (en) 2002-11-20 2009-02-17 Bestewil Holding B.V. Compositions comprising antigen-complexes, method of making same as well as methods of using the antigen-complexes for vaccination
EP1578443B1 (en) * 2002-11-20 2011-01-12 Bestewil Holding B.V. Compositions comprising antigen-complexes, method for making same as well as methods of using the antigen-complexes for vaccination
WO2004098569A1 (en) * 2003-04-18 2004-11-18 Northeastern University Micelle delivery system loaded with a pharmaceutical agent
US7262253B2 (en) * 2003-12-02 2007-08-28 Labopharm, Inc. Process for the preparation of amphiphilic poly (N-vinyl-2-pyrrolidone) block copolymers
CN100386115C (zh) * 2004-10-14 2008-05-07 孔庆忠 一种抗癌药物组合物
US8178129B2 (en) 2004-11-02 2012-05-15 Tel-Aviv University Future Technology Development L.P. Formulations of water insoluble or poorly water soluble drugs in lipidated glycosaminoglycan particles and their use for diagnostic and therapy
US20060198891A1 (en) * 2004-11-29 2006-09-07 Francois Ravenelle Solid formulations of liquid biologically active agents
WO2007014445A1 (en) * 2005-08-02 2007-02-08 Miv Therapeutics Inc. Microdevices comprising nanocapsules for controlled delivery of drugs and method of manufacturing same
US20070106271A1 (en) * 2005-11-09 2007-05-10 Searete Llc, A Limited Liability Corporation Remote control of substance delivery system
PL1962805T3 (pl) 2005-12-08 2017-01-31 Insmed Incorporated Kompozycje środków przeciwzapalnych oparte na lipidach do leczenia infekcji płucnych
KR101872061B1 (ko) 2005-12-19 2018-06-27 파마인 코포레이션 치료제를 전달하기 위한 소수성 코어 담체 조성물, 이 조성물의 제조 방법 및 그 조성물의 이용 방법
WO2007073596A1 (en) * 2005-12-27 2007-07-05 Labopharm Inc. Degradable polymeric microsphere composition
EP2011516A4 (en) * 2006-04-24 2010-06-23 Nanocarrier Co Ltd PROCESS FOR THE PRODUCTION OF A POLYMERIC MICELLE THAT CONTAINS A CHEMICAL PRODUCT OF LOW MOLECULAR WEIGHT ENCAPSULATED IN IT
CN100434120C (zh) * 2006-09-14 2008-11-19 同济大学 两亲性荧光靶向纳米胶束及其制备方法
AU2007298674A1 (en) * 2006-09-22 2008-03-27 Labopharm (Barbados) Limited Compositions and methods for pH targeted drug delivery
CN101583379B (zh) * 2006-10-05 2013-04-03 约翰斯霍普金斯大学 使用优良聚合物纳米粒子的水溶性差药物的水可分散性口服,肠胃外和局部制剂
US7758635B2 (en) * 2007-02-13 2010-07-20 Boston Scientific Scimed, Inc. Medical device including cylindrical micelles
WO2008137717A1 (en) 2007-05-04 2008-11-13 Transave, Inc. Compositions of multicationic drugs for reducing interactions with polyanionic biomolecules and methods and uses thereof
US9114081B2 (en) 2007-05-07 2015-08-25 Insmed Incorporated Methods of treating pulmonary disorders with liposomal amikacin formulations
US9119783B2 (en) 2007-05-07 2015-09-01 Insmed Incorporated Method of treating pulmonary disorders with liposomal amikacin formulations
US9333214B2 (en) 2007-05-07 2016-05-10 Insmed Incorporated Method for treating pulmonary disorders with liposomal amikacin formulations
US7960336B2 (en) 2007-08-03 2011-06-14 Pharmain Corporation Composition for long-acting peptide analogs
US8563527B2 (en) * 2007-08-20 2013-10-22 Pharmain Corporation Oligonucleotide core carrier compositions for delivery of nucleic acid-containing therapeutic agents, methods of making and using the same
WO2009064442A1 (en) * 2007-11-13 2009-05-22 Brookwood Pharmaceuticals, Inc. Viscous terpolymers as drug delivery platform
US20090176892A1 (en) 2008-01-09 2009-07-09 Pharmain Corporation Soluble Hydrophobic Core Carrier Compositions for Delivery of Therapeutic Agents, Methods of Making and Using the Same
CA2635187A1 (en) 2008-06-05 2009-12-05 The Royal Institution For The Advancement Of Learning/Mcgill University Oligonucleotide duplexes and uses thereof
US8974808B2 (en) 2008-12-23 2015-03-10 Surmodics, Inc. Elastic implantable composites and implants comprising same
US9415197B2 (en) * 2008-12-23 2016-08-16 Surmodics, Inc. Implantable suction cup composites and implants comprising same
US9480643B2 (en) 2008-12-23 2016-11-01 Surmodics Pharmaceuticals, Inc. Implantable composites and implants comprising same
US20100168807A1 (en) * 2008-12-23 2010-07-01 Burton Kevin W Bioactive terpolymer compositions and methods of making and using same
US8951546B2 (en) * 2008-12-23 2015-02-10 Surmodics Pharmaceuticals, Inc. Flexible implantable composites and implants comprising same
US8524784B2 (en) * 2009-04-30 2013-09-03 Intezyne Technologies, Incorporated Polymer micelles containing anthracylines for the treatment of cancer
WO2010127271A1 (en) 2009-04-30 2010-11-04 Intezyne Technologies, Incorporated Polymer micelles containing anthracylines for the treatment of cancer
WO2011119262A1 (en) 2010-03-26 2011-09-29 Cerulean Pharma Inc. Methods and systems for generating nanoparticles
US20130039864A1 (en) * 2010-04-23 2013-02-14 Francois Ravenelle Non-Intravenous Dosage Form Comprising Solid Formulation of Liquid Biologically Active Agent and Uses Thereof
US9416221B2 (en) 2010-08-30 2016-08-16 Surmodics, Inc. Biodegradable terpolymers and terpolymer blends as pressure-sensitive adhesives
CN101953804A (zh) * 2010-09-26 2011-01-26 苏州同科生物材料有限公司 基于两亲性嵌段共聚物的壳层可脱落式纳米药物载体制剂及其制备方法
US8546521B2 (en) 2011-01-28 2013-10-01 Cerulean Pharma Inc. Method for fabricating nanoparticles
CN102793678B (zh) * 2011-05-26 2017-06-30 邓世明 一种不含吐温的多烯紫杉醇注射剂的制备方法
WO2013052012A1 (en) * 2011-10-03 2013-04-11 Nanyang Technological University Cationic peptidopolysaccharides with excellent broad- spectrum antimicrobial activities and high selectivity
RU2480479C1 (ru) * 2011-11-01 2013-04-27 Елена Викторовна Свирщевская Гетерологичный пептидный мини-антиген в составе полимерной частицы для создания противоаллергенной вакцины
CN104105729B (zh) * 2012-02-10 2016-10-26 纳幕尔杜邦公司 高-x两嵌段共聚物的制备、纯化和使用
RU2501570C1 (ru) * 2012-05-11 2013-12-20 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "Казанский (Приволжский) федеральный университет" (ФГАОУВПО КФУ) Трехфункциональные блоксополимеры этиленоксида и пропиленоксида для доставки активных веществ в живые клетки
JP6402097B2 (ja) 2012-05-21 2018-10-10 インスメッド インコーポレイテッド 肺感染症を処置するためのシステム
ES2743039T3 (es) 2012-11-29 2020-02-18 Insmed Inc Formulaciones de vancomicina estabilizada
CN104434876B (zh) * 2013-09-13 2018-04-27 布里吉·P·吉里 用于癌症疗法及成像的缺氧-标靶聚合微胞
US10238675B2 (en) 2014-05-15 2019-03-26 Insmed Incorporated Methods for treating pulmonary non-tuberculous mycobacterial infections
KR102088663B1 (ko) * 2018-03-20 2020-03-13 한국세라믹기술원 친수성 및 소수성 약물의 동시 전달을 위한 온도민감성 나노스펀지 플랫폼 및 이의 용도
WO2019191627A1 (en) 2018-03-30 2019-10-03 Insmed Incorporated Methods for continuous manufacture of liposomal drug products
CN111592663B (zh) * 2020-03-27 2022-09-16 青岛大学 一种冠醚修饰的嵌段共聚物胶束的制备方法及其应用
CN114246831A (zh) * 2020-09-22 2022-03-29 鲁南制药集团股份有限公司 一种注射用紫杉烷类抗肿瘤药物的聚合物胶束冻干制剂

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE37983T1 (de) * 1982-04-22 1988-11-15 Ici Plc Mittel mit verzoegerter freigabe.
JP2517760B2 (ja) * 1989-05-11 1996-07-24 新技術事業団 水溶性高分子化医薬製剤
US5484778C1 (en) * 1990-07-17 2001-05-08 Univ Cleveland Hospitals Phthalocynine photosensitizers for photodynamic therapy and methods for their use
US5484612A (en) * 1993-09-22 1996-01-16 The Board Of Trustees Of The Leland Stanford Junior University Method of treating a mammal having a solid tumor susceptible to treatment with cisplatin
KR0180334B1 (ko) * 1995-09-21 1999-03-20 김윤 블럭 공중합체 미셀을 이용한 약물전달체 및 이에 약물을 봉입하는 방법
BR9606674B1 (pt) * 1995-09-29 2010-08-10 novo derivado de composto de antraciclina e preparação farmacêutica contendo o mesmo.
US5702717A (en) * 1995-10-25 1997-12-30 Macromed, Inc. Thermosensitive biodegradable polymers based on poly(ether-ester)block copolymers
JP3523821B2 (ja) * 2000-02-09 2004-04-26 ナノキャリア株式会社 薬物が封入されたポリマーミセルの製造方法および該ポリマーミセル組成物
AU2001276627A1 (en) * 2000-05-17 2001-11-26 Labopharm Inc. Drug containing polymeric micelles

Also Published As

Publication number Publication date
AU2001270405B2 (en) 2005-01-20
DE60122335D1 (de) 2006-09-28
CA2414241C (en) 2011-04-12
RU2308943C2 (ru) 2007-10-27
KR20030039332A (ko) 2003-05-17
MXPA03000065A (es) 2004-04-02
ATE336229T1 (de) 2006-09-15
JP5134179B2 (ja) 2013-01-30
CN1258358C (zh) 2006-06-07
HK1059395A1 (en) 2004-07-02
PL202475B1 (pl) 2009-06-30
EP1296647B1 (en) 2006-08-16
US6338859B1 (en) 2002-01-15
CZ302369B6 (cs) 2011-04-13
WO2002000194A2 (en) 2002-01-03
ES2271039T3 (es) 2007-04-16
CZ20024268A3 (cs) 2003-05-14
NZ523645A (en) 2004-09-24
CA2414241A1 (en) 2002-01-03
EP1296647A2 (en) 2003-04-02
AU7040501A (en) 2002-01-08
DE60122335T2 (de) 2007-08-30
PT1296647E (pt) 2006-12-29
HUP0300963A2 (hu) 2003-09-29
DK1296647T3 (da) 2006-12-27
IL153655A0 (en) 2003-07-06
JP2004501180A (ja) 2004-01-15
PL360262A1 (en) 2004-09-06
CN1447683A (zh) 2003-10-08
NO20026255D0 (no) 2002-12-27
WO2002000194A3 (en) 2002-08-08
BR0112054A (pt) 2003-09-30
IL153655A (en) 2008-11-26

Similar Documents

Publication Publication Date Title
NO20026255L (no) Polymere micellesammensetninger
DE602004027936D1 (de) Tocopherolmodifizierte therapeutische arzneimittelverbindung
CY1108532T1 (el) Ενωσεις και συνθεσεις για την παροχη δραστικων παραγοντων
CY1116075T1 (el) Νεες συνθεσεις λιποσωματων
MXPA03007837A (es) Composiciones para suministrar bisfosfonatos.
BR0114799A (pt) Compostos de ácido cianofenoxi carboxìlico e composições para liberar agentes ativos
MY129263A (en) Vaccine composition
HUP0300590A2 (hu) Peptidázzal hasítható, célzott antineoplasztikus szerek és terápiás alkalmazásuk
GEP20063741B (en) Nonaryl-Heterocyclic NMDA/NR2B Antagonists
BRPI0409133A (pt) formulações farmacêuticas contendo metilnaltrexona
BG66093B1 (bg) Състави с контролирано освобождаване, съдържащи нимесулид
HN2001000243A (es) Inhibidores de metaloproteinasa del tipo pirimidin - 2, 4, 6 - triona
HN2001000244A (es) Inhibidores de espiropirimidin - 2, 4, 6 - triona metaloproteinasas.
CY1107054T1 (el) Ενωσεις διτοσυλικου αλατος κιναζολινης
DE60038183D1 (de) Verbindungen und zusammensetzungen zur abgabe aktiver wirkstoffe
CY1105953T1 (el) Συνθεσεις για απελευθερωση συνδυασμων φαρμακων
NO20063393L (no) Farmasoytiske preparater
MXPA03007857A (es) Compuestos y composiciones para entregar agentes activos.
EA200600403A1 (ru) Препараты кладрибина для улучшенной пероральной доставки и доставки через слизистые оболочки
BG106008A (en) Novel lhrh antagonists with improved solubility characteristics
PT1107793E (pt) Conjugados de dextrano-leptina, composicoes farmaceuticas e processos relacionados
SE0300457D0 (sv) Novel compounds
GB0327390D0 (en) Pharmaceutical formulations
SE0001631D0 (sv) New use
DE60235549D1 (de) Pharmazeutische formulierung und darin enthaltende liganden; uea-1 mimetika

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application